메뉴 건너뛰기




Volumn 16, Issue 1, 2016, Pages

Treatment with anti-IL-6 receptor antibody prevented increase in serum hepcidin levels and improved anemia in mice inoculated with IL-6-producing lung carcinoma cells

Author keywords

Anemia; Cancer; Hepcidin; Interleukin 6; Iron metabolism

Indexed keywords

ANTIIDIOTYPIC ANTIBODY; HEPCIDIN; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; IRON;

EID: 84963627064     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/s12885-016-2305-2     Document Type: Article
Times cited : (27)

References (44)
  • 1
    • 84924418925 scopus 로고    scopus 로고
    • Anemia: progress in molecular mechanisms and therapies
    • Sankaran VG, Weiss MJ. Anemia: progress in molecular mechanisms and therapies. Nat Med. 2015;21(3):221-30. doi: 10.1038/nm.3814.
    • (2015) Nat Med , vol.21 , Issue.3 , pp. 221-230
    • Sankaran, V.G.1    Weiss, M.J.2
  • 2
    • 42949127743 scopus 로고    scopus 로고
    • Anaemia of cancer: an overview of mechanisms involved in its pathogenesis
    • Grotto HZ. Anaemia of cancer: an overview of mechanisms involved in its pathogenesis. Med Oncol. 2008;25(1):12-21. doi: 10.1007/s12032-007-9000-8.
    • (2008) Med Oncol , vol.25 , Issue.1 , pp. 12-21
    • Grotto, H.Z.1
  • 3
    • 5344263788 scopus 로고    scopus 로고
    • The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients
    • Ludwig H, Van Belle S, Barrett-Lee P, Birgegard G, Bokemeyer C, Gascon P, et al. The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients. Eur J Cancer. 2004;40(15):2293-306. doi: 10.1016/j.ejca.2004.06.019.
    • (2004) Eur J Cancer , vol.40 , Issue.15 , pp. 2293-2306
    • Ludwig, H.1    Belle, S.2    Barrett-Lee, P.3    Birgegard, G.4    Bokemeyer, C.5    Gascon, P.6
  • 4
    • 33644862202 scopus 로고    scopus 로고
    • Iron imports. IV. Hepcidin and regulation of body iron metabolism
    • Ganz T, Nemeth E. Iron imports. IV. Hepcidin and regulation of body iron metabolism. Am J Physiol Gastrointest Liver Physiol. 2006;290(2):G199-203. doi: 10.1152/ajpgi.00412.2005.
    • (2006) Am J Physiol Gastrointest Liver Physiol , vol.290 , Issue.2 , pp. G199-203
    • Ganz, T.1    Nemeth, E.2
  • 5
    • 84885768132 scopus 로고    scopus 로고
    • Systemic iron homeostasis
    • Ganz T. Systemic iron homeostasis. Physiol Rev. 2013;93(4):1721-41. doi: 10.1152/physrev.00008.2013.
    • (2013) Physiol Rev , vol.93 , Issue.4 , pp. 1721-1741
    • Ganz, T.1
  • 6
    • 33750133047 scopus 로고    scopus 로고
    • Regulation of iron metabolism by hepcidin
    • Nemeth E, Ganz T. Regulation of iron metabolism by hepcidin. Annu Rev Nutr. 2006;26:323-42. doi: 10.1146/annurev.nutr.26.061505.111303.
    • (2006) Annu Rev Nutr , vol.26 , pp. 323-342
    • Nemeth, E.1    Ganz, T.2
  • 7
    • 35648995976 scopus 로고    scopus 로고
    • Interleukin-6 and its receptor in cancer: implications for translational therapeutics
    • Hong DS, Angelo LS, Kurzrock R. Interleukin-6 and its receptor in cancer: implications for translational therapeutics. Cancer. 2007;110(9):1911-28. doi: 10.1002/cncr.22999.
    • (2007) Cancer , vol.110 , Issue.9 , pp. 1911-1928
    • Hong, D.S.1    Angelo, L.S.2    Kurzrock, R.3
  • 8
    • 22044438662 scopus 로고    scopus 로고
    • Hemoglobin levels correlate with interleukin-6 levels in patients with advanced untreated epithelial ovarian cancer: role of inflammation in cancer-related anemia
    • Maccio A, Madeddu C, Massa D, Mudu MC, Lusso MR, Gramignano G, et al. Hemoglobin levels correlate with interleukin-6 levels in patients with advanced untreated epithelial ovarian cancer: role of inflammation in cancer-related anemia. Blood. 2005;106(1):362-7. doi: 10.1182/blood-2005-01-0160.
    • (2005) Blood , vol.106 , Issue.1 , pp. 362-367
    • Maccio, A.1    Madeddu, C.2    Massa, D.3    Mudu, M.C.4    Lusso, M.R.5    Gramignano, G.6
  • 9
    • 0029096426 scopus 로고
    • Recombinant human interleukin-6 induces a rapid and reversible anemia in cancer patients
    • Nieken J, Mulder NH, Buter J, Vellenga E, Limburg PC, Piers DA, et al. Recombinant human interleukin-6 induces a rapid and reversible anemia in cancer patients. Blood. 1995;86(3):900-5.
    • (1995) Blood , vol.86 , Issue.3 , pp. 900-905
    • Nieken, J.1    Mulder, N.H.2    Buter, J.3    Vellenga, E.4    Limburg, P.C.5    Piers, D.A.6
  • 10
    • 33751175421 scopus 로고    scopus 로고
    • Interleukin-6 induces hepcidin expression through STAT3
    • Wrighting DM, Andrews NC. Interleukin-6 induces hepcidin expression through STAT3. Blood. 2006;108(9):3204-9. doi: 10.1182/blood-2006-06-027631.
    • (2006) Blood , vol.108 , Issue.9 , pp. 3204-3209
    • Wrighting, D.M.1    Andrews, N.C.2
  • 11
    • 47049116150 scopus 로고    scopus 로고
    • Erythropoietin mediates hepcidin expression in hepatocytes through EPOR signaling and regulation of C/EBPalpha
    • Pinto JP, Ribeiro S, Pontes H, Thowfeequ S, Tosh D, Carvalho F, et al. Erythropoietin mediates hepcidin expression in hepatocytes through EPOR signaling and regulation of C/EBPalpha. Blood. 2008;111(12):5727-33. doi: 10.1182/blood-2007-08-106195.
    • (2008) Blood , vol.111 , Issue.12 , pp. 5727-5733
    • Pinto, J.P.1    Ribeiro, S.2    Pontes, H.3    Thowfeequ, S.4    Tosh, D.5    Carvalho, F.6
  • 12
    • 34247523321 scopus 로고    scopus 로고
    • Regulation of hepcidin in HepG2 and RINm5F cells
    • Fein E, Merle U, Ehehalt R, Herrmann T, Kulaksiz H. Regulation of hepcidin in HepG2 and RINm5F cells. Peptides. 2007;28(5):951-7. doi: 10.1016/j.peptides.2007.01.016.
    • (2007) Peptides , vol.28 , Issue.5 , pp. 951-957
    • Fein, E.1    Merle, U.2    Ehehalt, R.3    Herrmann, T.4    Kulaksiz, H.5
  • 13
    • 13544252463 scopus 로고    scopus 로고
    • Hepcidin excess induces the sequestration of iron and exacerbates tumor-associated anemia
    • Rivera S, Liu L, Nemeth E, Gabayan V, Sorensen OE, Ganz T. Hepcidin excess induces the sequestration of iron and exacerbates tumor-associated anemia. Blood. 2005;105(4):1797-802. doi: 10.1182/blood-2004-08-3375.
    • (2005) Blood , vol.105 , Issue.4 , pp. 1797-1802
    • Rivera, S.1    Liu, L.2    Nemeth, E.3    Gabayan, V.4    Sorensen, O.E.5    Ganz, T.6
  • 14
    • 2342510407 scopus 로고    scopus 로고
    • IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin
    • Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, Pedersen BK, et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest. 2004;113(9):1271-6. doi: 10.1172/jci20945.
    • (2004) J Clin Invest , vol.113 , Issue.9 , pp. 1271-1276
    • Nemeth, E.1    Rivera, S.2    Gabayan, V.3    Keller, C.4    Taudorf, S.5    Pedersen, B.K.6
  • 15
    • 34347219438 scopus 로고    scopus 로고
    • Anti-interleukin 6 receptor antibody tocilizumab reduces the level of serum hepcidin in patients with multicentric Castleman's disease
    • Kawabata H, Tomosugi N, Kanda J, Tanaka Y, Yoshizaki K, Uchiyama T. Anti-interleukin 6 receptor antibody tocilizumab reduces the level of serum hepcidin in patients with multicentric Castleman's disease. Haematologica. 2007;92(6):857-8.
    • (2007) Haematologica , vol.92 , Issue.6 , pp. 857-858
    • Kawabata, H.1    Tomosugi, N.2    Kanda, J.3    Tanaka, Y.4    Yoshizaki, K.5    Uchiyama, T.6
  • 16
    • 78149324897 scopus 로고    scopus 로고
    • Down-regulation of hepcidin resulting from long-term treatment with an anti-IL-6 receptor antibody (tocilizumab) improves anemia of inflammation in multicentric Castleman disease
    • Song SN, Tomosugi N, Kawabata H, Ishikawa T, Nishikawa T, Yoshizaki K. Down-regulation of hepcidin resulting from long-term treatment with an anti-IL-6 receptor antibody (tocilizumab) improves anemia of inflammation in multicentric Castleman disease. Blood. 2010;116(18):3627-34. doi: 10.1182/blood-2010-03-271791.
    • (2010) Blood , vol.116 , Issue.18 , pp. 3627-3634
    • Song, S.N.1    Tomosugi, N.2    Kawabata, H.3    Ishikawa, T.4    Nishikawa, T.5    Yoshizaki, K.6
  • 17
    • 66749095300 scopus 로고    scopus 로고
    • Novel models of cancer-related anemia in mice inoculated with IL-6-producing tumor cells
    • Mori K, Fujimoto-Ouchi K, Onuma E, Noguchi M, Shimonaka Y, Yasuno H, et al. Novel models of cancer-related anemia in mice inoculated with IL-6-producing tumor cells. Biomed Res. 2009;30(1):47-51.
    • (2009) Biomed Res , vol.30 , Issue.1 , pp. 47-51
    • Mori, K.1    Fujimoto-Ouchi, K.2    Onuma, E.3    Noguchi, M.4    Shimonaka, Y.5    Yasuno, H.6
  • 18
    • 22244464504 scopus 로고    scopus 로고
    • Parathyroid hormone-related protein (PTHrP) as a causative factor of cancer-associated wasting: possible involvement of PTHrP in the repression of locomotor activity in rats bearing human tumor xenografts
    • Onuma E, Tsunenari T, Saito H, Sato K, Yamada-Okabe H, Ogata E. Parathyroid hormone-related protein (PTHrP) as a causative factor of cancer-associated wasting: possible involvement of PTHrP in the repression of locomotor activity in rats bearing human tumor xenografts. Int J Cancer. 2005;116(3):471-8. doi: 10.1002/ijc.21038.
    • (2005) Int J Cancer , vol.116 , Issue.3 , pp. 471-478
    • Onuma, E.1    Tsunenari, T.2    Saito, H.3    Sato, K.4    Yamada-Okabe, H.5    Ogata, E.6
  • 20
    • 37649012006 scopus 로고    scopus 로고
    • Simple and sensitive quantification of bioactive peptides in biological matrices using liquid chromatography/selected reaction monitoring mass spectrometry coupled with trichloroacetic acid clean-up
    • Murao N, Ishigai M, Yasuno H, Shimonaka Y, Aso Y. Simple and sensitive quantification of bioactive peptides in biological matrices using liquid chromatography/selected reaction monitoring mass spectrometry coupled with trichloroacetic acid clean-up. Rapid Commun Mass Spectrom. 2007;21(24):4033-8. doi: 10.1002/rcm.3319.
    • (2007) Rapid Commun Mass Spectrom , vol.21 , Issue.24 , pp. 4033-4038
    • Murao, N.1    Ishigai, M.2    Yasuno, H.3    Shimonaka, Y.4    Aso, Y.5
  • 21
    • 84875253909 scopus 로고    scopus 로고
    • Erythropoietin stimulation decreases hepcidin expression through hematopoietic activity on bone marrow cells in mice
    • Sasaki Y, Noguchi-Sasaki M, Yasuno H, Yorozu K, Shimonaka Y. Erythropoietin stimulation decreases hepcidin expression through hematopoietic activity on bone marrow cells in mice. Int J Hematol. 2012;96(6):692-700. doi: 10.1007/s12185-012-1217-4.
    • (2012) Int J Hematol , vol.96 , Issue.6 , pp. 692-700
    • Sasaki, Y.1    Noguchi-Sasaki, M.2    Yasuno, H.3    Yorozu, K.4    Shimonaka, Y.5
  • 23
    • 0345743620 scopus 로고    scopus 로고
    • IL-6 plays a critical role in the synergistic induction of human serum amyloid A (SAA) gene when stimulated with proinflammatory cytokines as analyzed with an SAA isoform real-time quantitative RT-PCR assay system
    • Hagihara K, Nishikawa T, Isobe T, Song J, Sugamata Y, Yoshizaki K. IL-6 plays a critical role in the synergistic induction of human serum amyloid A (SAA) gene when stimulated with proinflammatory cytokines as analyzed with an SAA isoform real-time quantitative RT-PCR assay system. Biochem Biophys Res Commun. 2004;314(2):363-9.
    • (2004) Biochem Biophys Res Commun , vol.314 , Issue.2 , pp. 363-369
    • Hagihara, K.1    Nishikawa, T.2    Isobe, T.3    Song, J.4    Sugamata, Y.5    Yoshizaki, K.6
  • 24
    • 2342644926 scopus 로고    scopus 로고
    • Oxygen sensing by HIF hydroxylases
    • Schofield CJ, Ratcliffe PJ. Oxygen sensing by HIF hydroxylases. Nat Rev Mol Cell Biol. 2004;5(5):343-54. doi: 10.1038/nrm1366.
    • (2004) Nat Rev Mol Cell Biol , vol.5 , Issue.5 , pp. 343-354
    • Schofield, C.J.1    Ratcliffe, P.J.2
  • 25
    • 0032805582 scopus 로고    scopus 로고
    • Role of cytokines in the pathogenesis of anemia of chronic disease in rheumatoid arthritis
    • Voulgari PV, Kolios G, Papadopoulos GK, Katsaraki A, Seferiadis K, Drosos AA. Role of cytokines in the pathogenesis of anemia of chronic disease in rheumatoid arthritis. Clin Immunol. 1999;92(2):153-60. doi: 10.1006/clim.1999.4736.
    • (1999) Clin Immunol , vol.92 , Issue.2 , pp. 153-160
    • Voulgari, P.V.1    Kolios, G.2    Papadopoulos, G.K.3    Katsaraki, A.4    Seferiadis, K.5    Drosos, A.A.6
  • 26
    • 0030808921 scopus 로고    scopus 로고
    • Elevated levels of inflammatory cytokines in bone marrow of patients with rheumatoid arthritis and anemia of chronic disease
    • Jongen-Lavrencic M, Peeters HR, Wognum A, Vreugdenhil G, Breedveld FC, Swaak AJ. Elevated levels of inflammatory cytokines in bone marrow of patients with rheumatoid arthritis and anemia of chronic disease. J Rheumatol. 1997;24(8):1504-9.
    • (1997) J Rheumatol , vol.24 , Issue.8 , pp. 1504-1509
    • Jongen-Lavrencic, M.1    Peeters, H.R.2    Wognum, A.3    Vreugdenhil, G.4    Breedveld, F.C.5    Swaak, A.J.6
  • 27
    • 0028206058 scopus 로고
    • Remarkable elevation of interleukin 6 and interleukin 8 levels in the bone marrow serum of patients with rheumatoid arthritis
    • Tanabe M, Ochi T, Tomita T, Suzuki R, Sakata T, Shimaoka Y, et al. Remarkable elevation of interleukin 6 and interleukin 8 levels in the bone marrow serum of patients with rheumatoid arthritis. J Rheumatol. 1994;21(5):830-5.
    • (1994) J Rheumatol , vol.21 , Issue.5 , pp. 830-835
    • Tanabe, M.1    Ochi, T.2    Tomita, T.3    Suzuki, R.4    Sakata, T.5    Shimaoka, Y.6
  • 28
    • 84891903512 scopus 로고    scopus 로고
    • Interleukin-6 directly impairs the erythroid development of human TF-1 erythroleukemic cells
    • McCranor BJ, Kim MJ, Cruz NM, Xue QL, Berger AE, Walston JD, et al. Interleukin-6 directly impairs the erythroid development of human TF-1 erythroleukemic cells. Blood Cells Mol Dis. 2014;52(2-3):126-33. doi: 10.1016/j.bcmd.2013.09.004.
    • (2014) Blood Cells Mol Dis , vol.52 , Issue.2-3 , pp. 126-133
    • McCranor, B.J.1    Kim, M.J.2    Cruz, N.M.3    Xue, Q.L.4    Berger, A.E.5    Walston, J.D.6
  • 29
  • 31
    • 33745742487 scopus 로고    scopus 로고
    • Hepcidin mRNA levels in mouse liver respond to inhibition of erythropoiesis
    • Vokurka M, Krijt J, Sulc K, Necas E. Hepcidin mRNA levels in mouse liver respond to inhibition of erythropoiesis. Physiol Res. 2006;55(6):667-74.
    • (2006) Physiol Res , vol.55 , Issue.6 , pp. 667-674
    • Vokurka, M.1    Krijt, J.2    Sulc, K.3    Necas, E.4
  • 32
    • 0028180987 scopus 로고
    • The acute-phase protein alpha 1-antitrypsin inhibits growth and proliferation of human early erythroid progenitor cells (burst-forming units-erythroid) and of human erythroleukemic cells (K562) in vitro by interfering with transferrin iron uptake
    • Graziadei I, Gaggl S, Kaserbacher R, Braunsteiner H, Vogel W. The acute-phase protein alpha 1-antitrypsin inhibits growth and proliferation of human early erythroid progenitor cells (burst-forming units-erythroid) and of human erythroleukemic cells (K562) in vitro by interfering with transferrin iron uptake. Blood. 1994;83(1):260-8.
    • (1994) Blood , vol.83 , Issue.1 , pp. 260-268
    • Graziadei, I.1    Gaggl, S.2    Kaserbacher, R.3    Braunsteiner, H.4    Vogel, W.5
  • 33
    • 0037093202 scopus 로고    scopus 로고
    • Regulation of ferritin genes and protein
    • Torti FM, Torti SV. Regulation of ferritin genes and protein. Blood. 2002;99(10):3505-16.
    • (2002) Blood , vol.99 , Issue.10 , pp. 3505-3516
    • Torti, F.M.1    Torti, S.V.2
  • 34
    • 84879952087 scopus 로고    scopus 로고
    • Serum interleukin 6 before and after therapy with tocilizumab is a principal biomarker in patients with rheumatoid arthritis
    • Shimamoto K, Ito T, Ozaki Y, Amuro H, Tanaka A, Nishizawa T, et al. Serum interleukin 6 before and after therapy with tocilizumab is a principal biomarker in patients with rheumatoid arthritis. J Rheumatol. 2013;40(7):1074-81. doi: 10.3899/jrheum.121389.
    • (2013) J Rheumatol , vol.40 , Issue.7 , pp. 1074-1081
    • Shimamoto, K.1    Ito, T.2    Ozaki, Y.3    Amuro, H.4    Tanaka, A.5    Nishizawa, T.6
  • 35
    • 58149154996 scopus 로고    scopus 로고
    • Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease
    • Nishimoto N, Terao K, Mima T, Nakahara H, Takagi N, Kakehi T. Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease. Blood. 2008;112(10):3959-64. doi: 10.1182/blood-2008-05-155846.
    • (2008) Blood , vol.112 , Issue.10 , pp. 3959-3964
    • Nishimoto, N.1    Terao, K.2    Mima, T.3    Nakahara, H.4    Takagi, N.5    Kakehi, T.6
  • 36
    • 0141504266 scopus 로고    scopus 로고
    • Iron deficiency and erythropoiesis: new diagnostic approaches
    • Brugnara C. Iron deficiency and erythropoiesis: new diagnostic approaches. Clin Chem. 2003;49(10):1573-8.
    • (2003) Clin Chem , vol.49 , Issue.10 , pp. 1573-1578
    • Brugnara, C.1
  • 37
    • 0027533103 scopus 로고
    • Red blood cell regeneration induced by subcutaneous recombinant erythropoietin: iron-deficient erythropoiesis in iron-replete subjects
    • Brugnara C, Chambers LA, Malynn E, Goldberg MA, Kruskall MS. Red blood cell regeneration induced by subcutaneous recombinant erythropoietin: iron-deficient erythropoiesis in iron-replete subjects. Blood. 1993;81(4):956-64.
    • (1993) Blood , vol.81 , Issue.4 , pp. 956-964
    • Brugnara, C.1    Chambers, L.A.2    Malynn, E.3    Goldberg, M.A.4    Kruskall, M.S.5
  • 38
    • 84896491618 scopus 로고    scopus 로고
    • The IL-6 feed-forward loop: a driver of tumorigenesis
    • Chang Q, Daly L, Bromberg J. The IL-6 feed-forward loop: a driver of tumorigenesis. Semin Immunol. 2014;26(1):48-53. doi: 10.1016/j.smim.2014.01.007.
    • (2014) Semin Immunol , vol.26 , Issue.1 , pp. 48-53
    • Chang, Q.1    Daly, L.2    Bromberg, J.3
  • 39
    • 0028587318 scopus 로고
    • Structure-function analysis of human IL-6: identification of two distinct regions that are important for receptor binding
    • Hammacher A, Ward LD, Weinstock J, Treutlein H, Yasukawa K, Simpson RJ. Structure-function analysis of human IL-6: identification of two distinct regions that are important for receptor binding. Protein Sci. 1994;3(12):2280-93. doi: 10.1002/pro.5560031213.
    • (1994) Protein Sci , vol.3 , Issue.12 , pp. 2280-2293
    • Hammacher, A.1    Ward, L.D.2    Weinstock, J.3    Treutlein, H.4    Yasukawa, K.5    Simpson, R.J.6
  • 40
    • 84896495791 scopus 로고    scopus 로고
    • A new era for the treatment of inflammatory autoimmune diseases by interleukin-6 blockade strategy
    • Tanaka T, Narazaki M, Ogata A, Kishimoto T. A new era for the treatment of inflammatory autoimmune diseases by interleukin-6 blockade strategy. Semin Immunol. 2014;26(1):88-96. doi: 10.1016/j.smim.2014.01.009.
    • (2014) Semin Immunol , vol.26 , Issue.1 , pp. 88-96
    • Tanaka, T.1    Narazaki, M.2    Ogata, A.3    Kishimoto, T.4
  • 41
    • 84943791915 scopus 로고    scopus 로고
    • A phase I trial combining carboplatin/doxorubicin with tocilizumab, an anti-IL-6R monoclonal antibody, and interferon-alpha2b in patients with recurrent epithelial ovarian cancer
    • Dijkgraaf EM, Santegoets SJ, Reyners AK, Goedemans R, Wouters MC, Kenter GG, et al. A phase I trial combining carboplatin/doxorubicin with tocilizumab, an anti-IL-6R monoclonal antibody, and interferon-alpha2b in patients with recurrent epithelial ovarian cancer. Ann Oncol. 2015;26(10):2141-9. doi: 10.1093/annonc/mdv309.
    • (2015) Ann Oncol , vol.26 , Issue.10 , pp. 2141-2149
    • Dijkgraaf, E.M.1    Santegoets, S.J.2    Reyners, A.K.3    Goedemans, R.4    Wouters, M.C.5    Kenter, G.G.6
  • 42
    • 84875713812 scopus 로고    scopus 로고
    • Possible role for tocilizumab, an anti-interleukin-6 receptor antibody, in treating cancer cachexia
    • Ando K, Takahashi F, Motojima S, Nakashima K, Kaneko N, Hoshi K, et al. Possible role for tocilizumab, an anti-interleukin-6 receptor antibody, in treating cancer cachexia. J Clin Oncol. 2013;31(6):e69-72. doi: 10.1200/jco.2012.44.2020.
    • (2013) J Clin Oncol , vol.31 , Issue.6 , pp. e69-72
    • Ando, K.1    Takahashi, F.2    Motojima, S.3    Nakashima, K.4    Kaneko, N.5    Hoshi, K.6
  • 43
    • 84882451000 scopus 로고    scopus 로고
    • Favorable responses to tocilizumab in two patients with cancer-related cachexia
    • Hirata H, Tetsumoto S, Kijima T, Kida H, Kumagai T, Takahashi R, et al. Favorable responses to tocilizumab in two patients with cancer-related cachexia. J Pain Symptom Manage. 2013;46(2):e9-13. doi: 10.1016/j.jpainsymman.2013.01.009.
    • (2013) J Pain Symptom Manage , vol.46 , Issue.2 , pp. e9-13
    • Hirata, H.1    Tetsumoto, S.2    Kijima, T.3    Kida, H.4    Kumagai, T.5    Takahashi, R.6
  • 44
    • 84904184220 scopus 로고    scopus 로고
    • Tocilizumab, a proposed therapy for the cachexia of Interleukin6-expressing lung cancer
    • Ando K, Takahashi F, Kato M, Kaneko N, Doi T, Ohe Y, et al. Tocilizumab, a proposed therapy for the cachexia of Interleukin6-expressing lung cancer. PLoS One. 2014;9(7):e102436. doi: 10.1371/journal.pone.0102436.
    • (2014) PLoS One , vol.9 , Issue.7
    • Ando, K.1    Takahashi, F.2    Kato, M.3    Kaneko, N.4    Doi, T.5    Ohe, Y.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.